An introduction to mitotane and an overview of its market price

Mitotane, also known as mitotane medoxomil, is a drug with significant efficacy in the field of tumor treatment, specially used to treat adrenocortical cancer and its metastatic tumors. It achieves the effect of effectively controlling tumor growth by precisely inhibiting the synthesis and secretion of adrenocortical steroid hormones. Mitotane has undoubtedly become a vital treatment option for many patients with advanced or metastatic adrenocortical cancer.

The pharmacological effect of mitotane is quite unique. It can precisely destroy the mitochondrial function of adrenocortical cells, causing disorders in the metabolic process of these cells, and ultimately inducing cells to undergo apoptosis. It is this unique mechanism of action that makes mitotane outstanding in the treatment of adrenocortical tumors. It not only effectively extends the survival period of patients, but also plays a positive role in improving the quality of life of patients.

It is worth mentioning that mitotane also exhibits a certain anti-estrogen effect, which helps reduce the tumor's dependence on estrogen, thereby further curbing the growth of the tumor. However, like many powerful drugs, mitotane may be accompanied by some adverse reactions during use, such as gastrointestinal discomfort or liver function damage. Therefore, patients must strictly follow the doctor's instructions when using it.

With in-depth research on mitotane in recent years, scientists have found that it also shows great potential in the treatment of other types of tumors. Currently, scientific researchers are actively exploring the combined application of mitotane with other drugs, hoping to exert its excellent anti-tumor effects in a broader field of tumor treatment and bring new hope to more patients.

As for the market price of mitotane, this original drug carefully developed byHRA Pharma has already appeared in the domestic market. Although its time on the market in China is still short, we are currently unable to directly obtain detailed selling price data. However, according to relevant news, the drug is sold in the European market in the specification of 500mg*100 tablets, and the price is about 9,200 yuan, which is relatively affordable. At the same time, generic versions of mitotane have also been launched in overseas markets. For example, products produced by Laos ASEAN and Laos Lucius Pharmaceuticals are priced at approximately 3,900 yuan and 1,900 yuan respectively, providing patients with more choices. Of course, when choosing medications, patients must make informed decisions based on their doctors’ recommendations and their own actual conditions.

In summary, as a specific drug targeting adrenocortical cancer, mitotane’s importance in the field of tumor treatment is self-evident. As scientific research continues to deepen and advance, we have reason to believe that mitotane will bring hope and hope to more patients.